|
Day
|
An. gambiae
|
Cx. quinquefasciatus
|
|---|
|
No. experiments included
|
Mean % survival in ivermectin group*
|
Mean % survival in placebo group*
|
No. experiments included
|
Mean % survival in ivermectin group*
|
Mean % survival in placebo group*
|
|---|
|
0
|
15
|
100.0
|
100.0
|
15
|
100.0
|
100.0
|
|
1
|
15
|
93.4
|
99.5
|
15
|
97.1
|
99.9
|
|
2
|
15
|
52.3
|
97.2
|
15
|
95.7
|
98.4
|
|
3
|
15
|
33.8
|
95.6
|
15
|
93.5
|
97.8
|
|
4
|
15
|
21.2
|
94.2
|
15
|
92.8
|
97.8
|
|
5
|
15
|
13.3
|
92.6
|
15
|
91.7
|
96.7
|
|
6
|
15
|
10.3
|
91.3
|
13
|
89.6
|
95.3
|
|
7
|
13
|
7.0
|
87.6
|
13
|
88.9
|
94.9
|
|
8
|
6
|
6.0
|
86.8
|
13
|
85.5
|
89.8
|
|
9
|
2
|
5.0
|
88.0
|
13
|
83.6
|
88.0
|
|
10
|
1
|
0.0
|
80.0
|
13
|
80.4
|
86.4
|
|
11
|
1
|
0.0
|
80.0
|
12
|
75.1
|
85.7
|
|
12
|
1
|
0.0
|
80.0
|
9
|
80.3
|
86.4
|
- Calculated as mean of % survival in the individual experiments. For each of the two species, results from experiments were excluded when mortality in the placebo group exceeded 20%.
- *Mean for included experiments.
